Poseida Therapeutics, Inc. announced the appointment of Charles M. Baum to its board of directors, effective May 16, 2022. Additionally, the company announced the resignation of David Hirsch, from its board of directors, effective May 17, 2022. Dr. Baum is President, Head of Research and Development, and a member of the Board of Directors at Mirati Therapeutics Inc. Dr. Baum currently serves as Chairman of the Board at OncoMyx Therapeutics.